Recipharm

recipharm.com · Stockholm, Sweden

Recipharm is a global contract development and manufacturing organization (CDMO) that provides pharmaceutical companies with services spanning drug development, formulation, analytical testing, and commercial manufacturing of sterile and non-sterile products. It serves biotech and pharma clients with dose form development, clinical and commercial production, and packaging services on an outsourced basis. The company generates revenue through long-term manufacturing contracts and development service fees.

Revenue
$1.4B
Employees
9,500
Founded
1995
Headquarters
Stockholm, Sweden

What 14 Arbolus experts think of Recipharm

NPS scores cluster between 6 and 10, with the majority falling at 7–9, indicating moderate to high customer satisfaction. Renewal intent is split: about 33% express intent to renew, another third are unsure, and one instance of negative renewal is present. Stickiness is high among established customers, with over 75% reporting implementations longer than 1 year. Early-stage users (pilot and consistency in service delivery and regulatory reliability.Overall Customer Sentiment: Positive

Who reviewed Recipharm

Total customers 14 13 current · 1 former
Reviews growth +4 in six months
Seniority of respondents
  • C-Suite 57% (8)
  • Director 29% (4)
  • Manager 14% (2)
Not specified Manager NPS 8 Undecided
Strategy Leader C-Suite NPS 7
Data Leader Director NPS 10

Employer names and spend open once the report publishes.

Tell us when the Recipharm report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Notify me

Sentiment

42 Net Promoter Score, from 14 scored reviews
  • Promoters 7
  • Passives 6
  • Detractors 1

Cumulative NPS by month

+2 over 5 months
  • Dec 6
  • Jan 8
  • Feb 8
  • May 8
  • Sep 8

Net Promoter Score across 1 reviews, accumulated up to each month. Category median 42 across 1 companies.

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 40%
  • Will renew 2
  • Undecided 2
  • Not renewing 1

Plan to renew, by seniority

  • C-Suite 100% 2 answers
  • Director 0% 1 answer
  • Manager 0% 2 answers
  • 7.5/10 Average score from customers who will renew
  • 7/10 Average score from undecided customers
  • 7/10 Average score from customers not renewing

For people who use Recipharm

Do you use Recipharm at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 14 customers of Recipharm have already contributed
Share your experience

Takes a few minutes. Your identity stays anonymous.